Cadralazine

HCID 2515CAS 64241-34-5

Completing data — usually done within a minute

Basic information

Standard SMILES
CCOC(=O)NNc1ccc(N(CC)CC(C)O)nn1
InChIKey
QLTVVOATEHFXLT-UHFFFAOYSA-N
Molecular formula
C12H21N5O3
Average molar mass
283.332 g/mol
Monoisotopic mass
283.16443953

Names & identifiers

Preferred name
Cadralazine
IUPAC
Ethyl 2-{6-[ethyl(2-hydroxypropyl)amino]pyridazin-3-yl}hydrazine-1-carboxylate
English name
Cadralazine
Molecular formula
C12H21N5O3
Molecular weight
283.33

Names & synonyms

DC-26DC 826CadralISF-469CadrilanCadratenPresmodeISF 2469CGP 18684ECadralazine

Database identifiers

CAS
64241-34-5
PubChem CID
2515
DTXSID
DTXSID4048725
ChEMBL
CHEMBL2106561
ChEBI
CHEBI:31331
UNII
8T96I3U713
Nikkaji
J69.473H

Properties

Physicochemical properties

Melting point
160 · 160-162°
Boiling point
425.88 °C · 425.88°C (rough estimate)
Density
1.1585 · 1.1585 (rough estimate)
refractive index
1.65 · 1.6500 (estimate)
storage temp.
2 · 2-8°C
solubility
250 mg/mL · DMSO : 250 mg/mL (882.36 mM; ultrasonic and warming and heat to 60°C)

Safety & regulation

Safety data

Toxicity
LD50 in rats, dogs (mg/kg): 269, approx 400 i.v.; 2060, >2000 orally (Semeraro); in mice (mg/kg): 700 i.p. (Parravicini)

Chemistry & industry

Applications

DescriptionCadralazine is a vasodilatory antihypertensive reportedly better-tolerated and longer-acting than hydralazine. It is useful as a second-line treatment in the management of hypertension.

UsesCadralazine relaxes arterial smooth muscle, thereby reducing peripheral vascular resistance and lowering blood pressure. It is used for hypertension.

Upstream & downstream products

Suppliers29 total

沈阳中申泽康生物医学技术研究有限公司024-88590548 18698872706 · [email protected]
苏州启航生物科技有限公司18151111370 · [email protected]
上海毕得医药科技股份有限公司400-1647117 13681763483 · [email protected]
LGM Pharma1-(800)-881-8210 · [email protected]
北京索莱宝科技有限公司010-50973130 17801761073 · [email protected]

Additional notes

DefinitionChEBI: Cadralazine is an organic molecular entity.

Related reactions

2 records

Linked notes

Loading…